Philipp-Alexander Neumann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Philipp-Alexander Neumann has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
Helmut Friess
Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany
17 shared publications- Stefan Reischl
Department of Diagnostic and Interventional Radiology, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany
13 shared publications Dirk Wilhelm
Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
8 shared publications- Kamacay Cira
Klinik und Poliklinik für Chirurgie, TUM Klinikum, Rechts der Isar, TUM School of Medicine and Health, Technische Universität München, München, Deutschland
8 shared publications Atsuko Kasajima
Institute of General and Surgical Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany
7 shared publicationsMarie-Christin Weber
Department of Surgery, TUM University Hospital, Klinikum rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany
7 shared publications
Latest Publications
- 23 February 2026
- Published by Springer Nature in coloproctology
- Vol. 48 (2) , 113-121
Die Rolle des Mikrobioms bei chronisch-entzündlichen Darmerkrankungen
- 23 February 2026
- Published by Springer Nature in coloproctology
- Vol. 48 (2) , 113-121
Die Rolle des Mikrobioms bei chronisch-entzündlichen Darmerkrankungen
- Open Access
- 18 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (5) , 11552-11562
Feasibility and preliminary results of modeling a clinically meaningful anastomotic leak in pigs
Background: Animal models are essential for investigating the pathobiology of anastomotic leakage (AL). To be clinically meaningful, AL must occur despite a technically adequate anastomosis and reflect a phenotype relevant to surgical practice. This feasibility pilot study aimed to develop a clinically relevant porcine AL model by combining a Western diet (WD), segmental ischemia, perioperative antibiotic prophylaxis (PAP), and luminal exposure to pathogenic bacteria under optimal surgical conditions. Methods: Twenty-one female domestic pigs were randomized into four groups. Group 1 received standard chow, PAP, and underwent a stapled colorectal anastomosis. Group 2 received WD, PAP, and perioperative luminal exposure to viable human and murine pathogens via colonoscopy. Group 3 received the same treatment with added ischemia–reperfusion (I/R) injury. Group 4 served as a negative control, receiving all exposures with autoclaved pathogens. Animals underwent a technically optimal stapled colorectal anastomosis. Healing was assessed clinically, endoscopically, and macroscopically on postoperative days 3 and 7. Results: Gross healing ( P = 0.0027) and adhesion scores ( P = 0.0067) differed significantly between groups, with the highest scores in pigs exposed to WD, I/R, and viable pathogens. These changes did not reach the threshold of clinically overt anastomotic failure (Clavien–Dindo grade III), and endoscopic scores showed no significant intergroup differences. A strong association was observed between gross healing and adhesion scores ( r = 0.909). Conclusion: While the model did not progress to clinically overt AL (Clavien–Dindo grade III), it reproducibly induced subclinical impairment of anastomotic healing under compounded perioperative stress. These findings support its feasibility and biological relevance for studying early determinants of anastomotic integrity prior to clinical failure.
- 18 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (5) , 11552-11562
Open AccessFeasibility and preliminary results of modeling a clinically meaningful anastomotic leak in pigs
Background: Animal models are essential for investigating the pathobiology of anastomotic leakage (AL). To be clinically meaningful, AL must occur despite a technically adequate anastomosis and reflect a phenotype relevant to surgical practice. This feasibility pilot study aimed to develop a clinically relevant porcine AL model by combining a Western diet (WD), segmental ischemia, perioperative antibiotic prophylaxis (PAP), and luminal exposure to pathogenic bacteria under optimal surgical conditions. Methods: Twenty-one female domestic pigs were randomized into four groups. Group 1 received standard chow, PAP, and underwent a stapled colorectal anastomosis. Group 2 received WD, PAP, and perioperative luminal exposure to viable human and murine pathogens via colonoscopy. Group 3 received the same treatment with added ischemia–reperfusion (I/R) injury. Group 4 served as a negative control, receiving all exposures with autoclaved pathogens. Animals underwent a technically optimal stapled colorectal anastomosis. Healing was assessed clinically, endoscopically, and macroscopically on postoperative days 3 and 7. Results: Gross healing ( P = 0.0027) and adhesion scores ( P = 0.0067) differed significantly between groups, with the highest scores in pigs exposed to WD, I/R, and viable pathogens. These changes did not reach the threshold of clinically overt anastomotic failure (Clavien–Dindo grade III), and endoscopic scores showed no significant intergroup differences. A strong association was observed between gross healing and adhesion scores ( r = 0.909). Conclusion: While the model did not progress to clinically overt AL (Clavien–Dindo grade III), it reproducibly induced subclinical impairment of anastomotic healing under compounded perioperative stress. These findings support its feasibility and biological relevance for studying early determinants of anastomotic integrity prior to clinical failure.
- Open Access
- 5 September 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Perioperative Collagen IV-Targeted Ac2-26 Nanoparticles Enhance Anastomotic Healing in Acute Crohn’s Disease-Like Colitis
Objective: This preclinical study investigates a novel targeted collagen type IV nanoparticle formulation, Ac2-26 coated with chitosan and pectin ((pc)-Col-IV-Ac2-26-NPs), to promote anastomotic healing in a model of acute Crohn’s disease (CD) with distal colo-colonic anastomosis, using intraperitoneal, oral and rectal delivery to optimize therapeutic effects while minimizing systemic immunosuppression. Summary Background Data: Surgery remains critical for CD-patients due to irreversible tissue damage, with anti-inflammatory therapies increasing the risk of postoperative complications like anastomotic leaks. Method: Female BALB/c mice (n=152) with CD-like colitis (2,4,6-Trinitrobenzenesulfonic acid) were randomized to receive (pc)-Col-IV-Ac2-26-NPs or scrambled NPs intraperitoneally, orally, or rectally every 3.5 days pre- and postoperatively, followed by distal end-to-end colo-colonic anastomosis. Perioperative outcomes (weight loss, disease activity index (DAI)), anastomotic healing scores (endoscopic, histologic), and immunohistochemical (IHC) markers were assessed on postoperative days (POD) 3 and 7 Results: NPs accumulated selectively at the anastomosis in a route-dependent manner and associated with higher collagen expression (P+-M1 macrophages, all P+-M2 Macrophages, all PP=0.03) and both endoscopic (POD3:PPPP<0.0170) healing scores. While intraperitoneal delivery produced similar outcomes, oral delivery showed the weakest effect. Conclusion: (pc)-Col-IV-Ac2-26-NPs promote anastomotic healing during CD-colitis through targeted, route-dependent immunomodulation and tissue repair, with rectal delivery showing the highest local efficacy. These findings support their potential as locally acting, non-immunosuppressive therapy for high-risk CD-patients undergoing intestinal surgery.
- 5 September 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Open AccessPerioperative Collagen IV-Targeted Ac2-26 Nanoparticles Enhance Anastomotic Healing in Acute Crohn’s Disease-Like Colitis
Objective: This preclinical study investigates a novel targeted collagen type IV nanoparticle formulation, Ac2-26 coated with chitosan and pectin ((pc)-Col-IV-Ac2-26-NPs), to promote anastomotic healing in a model of acute Crohn’s disease (CD) with distal colo-colonic anastomosis, using intraperitoneal, oral and rectal delivery to optimize therapeutic effects while minimizing systemic immunosuppression. Summary Background Data: Surgery remains critical for CD-patients due to irreversible tissue damage, with anti-inflammatory therapies increasing the risk of postoperative complications like anastomotic leaks. Method: Female BALB/c mice (n=152) with CD-like colitis (2,4,6-Trinitrobenzenesulfonic acid) were randomized to receive (pc)-Col-IV-Ac2-26-NPs or scrambled NPs intraperitoneally, orally, or rectally every 3.5 days pre- and postoperatively, followed by distal end-to-end colo-colonic anastomosis. Perioperative outcomes (weight loss, disease activity index (DAI)), anastomotic healing scores (endoscopic, histologic), and immunohistochemical (IHC) markers were assessed on postoperative days (POD) 3 and 7 Results: NPs accumulated selectively at the anastomosis in a route-dependent manner and associated with higher collagen expression (P+-M1 macrophages, all P+-M2 Macrophages, all PP=0.03) and both endoscopic (POD3:PPPP<0.0170) healing scores. While intraperitoneal delivery produced similar outcomes, oral delivery showed the weakest effect. Conclusion: (pc)-Col-IV-Ac2-26-NPs promote anastomotic healing during CD-colitis through targeted, route-dependent immunomodulation and tissue repair, with rectal delivery showing the highest local efficacy. These findings support their potential as locally acting, non-immunosuppressive therapy for high-risk CD-patients undergoing intestinal surgery.
- Open Access
- 15 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (11) , 8050-8059
Low HS-Omega-3 index as a predictor of severe postoperative complications in abdominal surgery: a prospective observational study
Background: Omega-3 supplementation may reduce postoperative complications, but variability in formulations and lack of standardized monitoring limit its use. The HS-Omega-3 Index® offers a standardized measure of omega-3 status, but its role in surgical outcomes remains unexamined. This pilot prospective observational study investigated the association between preoperative HS-Omega-3 Index® and postoperative complications in patients undergoing major gastrointestinal or hepatobiliary surgeries, adopting a broad approach to assess its relevance. Method: This study included 269 patients undergoing elective gastrointestinal or hepatobiliary surgery between November 2020 and February 2023, excluding those receiving preoperative parenteral nutrition and other predefined criteria. Preoperative HS-Omega-3 Index® levels were measured and correlated with postoperative complications using the Clavien–Dindo (CD) classification. Logistic regression analysis, adjusted for confounders such as age, smoking status, sarcopenia, and visceral obesity, assessed the association between the HS-Omega-3 Index® and severe complications (CD≥3). Results: The HS-Omega-3 Index® was OR ], 0.72; P = 0.037). Conclusion: A reduced HS-Omega-3 Index® was highly prevalent in patients undergoing major abdominal surgery and was significantly associated with an increased risk of severe postoperative complications. These findings support the potential utility of the HS-Omega-3 Index® as a preoperative biomarker for risk stratification and for targeted prehabilitation strategies. Further studies are needed to confirm its impact on surgical outcomes.
- 15 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (11) , 8050-8059
Open AccessLow HS-Omega-3 index as a predictor of severe postoperative complications in abdominal surgery: a prospective observational study
Background: Omega-3 supplementation may reduce postoperative complications, but variability in formulations and lack of standardized monitoring limit its use. The HS-Omega-3 Index® offers a standardized measure of omega-3 status, but its role in surgical outcomes remains unexamined. This pilot prospective observational study investigated the association between preoperative HS-Omega-3 Index® and postoperative complications in patients undergoing major gastrointestinal or hepatobiliary surgeries, adopting a broad approach to assess its relevance. Method: This study included 269 patients undergoing elective gastrointestinal or hepatobiliary surgery between November 2020 and February 2023, excluding those receiving preoperative parenteral nutrition and other predefined criteria. Preoperative HS-Omega-3 Index® levels were measured and correlated with postoperative complications using the Clavien–Dindo (CD) classification. Logistic regression analysis, adjusted for confounders such as age, smoking status, sarcopenia, and visceral obesity, assessed the association between the HS-Omega-3 Index® and severe complications (CD≥3). Results: The HS-Omega-3 Index® was OR ], 0.72; P = 0.037). Conclusion: A reduced HS-Omega-3 Index® was highly prevalent in patients undergoing major abdominal surgery and was significantly associated with an increased risk of severe postoperative complications. These findings support the potential utility of the HS-Omega-3 Index® as a preoperative biomarker for risk stratification and for targeted prehabilitation strategies. Further studies are needed to confirm its impact on surgical outcomes.
- Open Access
- 7 July 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Timing of Antibiotic Prophylaxis Prior to Abdominal Surgery Has No Impact on Infectious Complications
Objective: To evaluate the impact of perioperative antibiotic prophylaxis (PAP) timing on postoperative infectious complications in abdominal surgery. Summary Background Data: Current guidelines advocate strict adherence to predefined PAP timing, yet evidence on its optimal window remains inconclusive. Methods: This single-center, retrospective matched cohort study, conducted at a high-volume university hospital in Germany (2013-2018), included 1,193 patients undergoing open elective CDC II-III abdominal surgeries. PAP timing was categorized as “on time” (OT: ≥30 m before incision) or “not on time” (NT:200 minutes. Antimicrobial resistance did not alter observed associations. Conclusion: PAP timing did not significantly affect in-hospital infectious complications following elective open abdominal surgery, and antimicrobial resistance did not confound this association. A rigid time-based approach may be less critical than assumed, warranting individualized strategies based on procedure length and resistance profiles.
- 7 July 2025
- Published by Wolters Kluwer Health in Annals of Surgery
Open AccessTiming of Antibiotic Prophylaxis Prior to Abdominal Surgery Has No Impact on Infectious Complications
Objective: To evaluate the impact of perioperative antibiotic prophylaxis (PAP) timing on postoperative infectious complications in abdominal surgery. Summary Background Data: Current guidelines advocate strict adherence to predefined PAP timing, yet evidence on its optimal window remains inconclusive. Methods: This single-center, retrospective matched cohort study, conducted at a high-volume university hospital in Germany (2013-2018), included 1,193 patients undergoing open elective CDC II-III abdominal surgeries. PAP timing was categorized as “on time” (OT: ≥30 m before incision) or “not on time” (NT:200 minutes. Antimicrobial resistance did not alter observed associations. Conclusion: PAP timing did not significantly affect in-hospital infectious complications following elective open abdominal surgery, and antimicrobial resistance did not confound this association. A rigid time-based approach may be less critical than assumed, warranting individualized strategies based on procedure length and resistance profiles.
- Open Access
Self-reported financial difficulties of colorectal cancer patients 1 year after start of treatment
- Open Access
- 29 January 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2953-2961
Incidence and treatment of anastomotic leakage after esophagectomy in German acute care hospitals: a retrospective cohort study
Background: Anastomotic leakage (AL) is a major concern following esophagectomy due to the associated morbidity and mortality. The impact of hospital volume on postoperative outcomes after esophagectomy has previously been reported. The aim of this study was to analyze the current trends in postoperative anastomotic leakage and associated failure-to-rescue after esophagectomy in relation to hospital volume in German acute care hospitals using real-world data from the German Diagnosis-Related Groups (G-DRG) database. Materials and methods: A retrospective secondary data analysis of the G-DRG database was performed for all in-hospital cases of patients undergoing esophagectomy from 2013 to 2021. AL and in-house mortality rates were assessed in relation to hospital case volume and endoscopic treatment modalities. Results: The study included 32 335 cases. The mean reported AL rate was 17.1% with a mean failure-to-rescue rate of 18.9%. AL rates did not differ between hospitals with an annual case-volume ≤ 25 procedures/year vs. >25 procedures/year (16.8% vs. 17.6%, OR 1.06, P = 0.07). However, in high-volume centers (> 25 procedures/year), in-hospital mortality for cases with AL (failure-to-rescue) was lower compared to medium-volume (10-25 cases/year) and low-volume (1-9 cases/year) centers (14.2% vs. 21.5% vs. 25.1%). The use of endoscopic vacuum therapy (EVT) increased over time, reaching 58.1% of AL cases in 2021 compared to 14.2% in 2013, while the use of self-expanding metal stents (SEMS) decreased from 37.0% in 2013 to 9.3% in 2021. Conclusions: AL rates after esophagectomy remain high. In-house mortality is significantly lower in high-volume hospitals highlighting the importance to consider improvements in centralization of procedures. Further efforts are needed to reduce AL rates and improve outcomes after esophagectomy.
- 29 January 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2953-2961
Open AccessIncidence and treatment of anastomotic leakage after esophagectomy in German acute care hospitals: a retrospective cohort study
Background: Anastomotic leakage (AL) is a major concern following esophagectomy due to the associated morbidity and mortality. The impact of hospital volume on postoperative outcomes after esophagectomy has previously been reported. The aim of this study was to analyze the current trends in postoperative anastomotic leakage and associated failure-to-rescue after esophagectomy in relation to hospital volume in German acute care hospitals using real-world data from the German Diagnosis-Related Groups (G-DRG) database. Materials and methods: A retrospective secondary data analysis of the G-DRG database was performed for all in-hospital cases of patients undergoing esophagectomy from 2013 to 2021. AL and in-house mortality rates were assessed in relation to hospital case volume and endoscopic treatment modalities. Results: The study included 32 335 cases. The mean reported AL rate was 17.1% with a mean failure-to-rescue rate of 18.9%. AL rates did not differ between hospitals with an annual case-volume ≤ 25 procedures/year vs. >25 procedures/year (16.8% vs. 17.6%, OR 1.06, P = 0.07). However, in high-volume centers (> 25 procedures/year), in-hospital mortality for cases with AL (failure-to-rescue) was lower compared to medium-volume (10-25 cases/year) and low-volume (1-9 cases/year) centers (14.2% vs. 21.5% vs. 25.1%). The use of endoscopic vacuum therapy (EVT) increased over time, reaching 58.1% of AL cases in 2021 compared to 14.2% in 2013, while the use of self-expanding metal stents (SEMS) decreased from 37.0% in 2013 to 9.3% in 2021. Conclusions: AL rates after esophagectomy remain high. In-house mortality is significantly lower in high-volume hospitals highlighting the importance to consider improvements in centralization of procedures. Further efforts are needed to reduce AL rates and improve outcomes after esophagectomy.
- Open Access
- 25 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery
Targeted perioperative therapeutics supporting anastomotic healing during colitis are an urgent medical need. This study aimed to develop and evaluate a novel nanoparticle (NP)-based drug delivery system for improving anastomotic healing in Inflammatory bowel disease (IBD) patients following surgery. We developed pectin-coated polymeric NPs encapsulating the inflammation-resolving peptide Ac2-26. These NPs are designed to survive gastric passage, facilitate localized release in the colon via microbial pectinase degradation, and bind to the intestinal wound through collagen IV targeting. We investigated these NPs in a murine surgical model combining intestinal anastomosis with preoperative colitis induction. Perioperative administration of pectin-chitosan coated NPs containing Ac2-26 (P-C-Col IV-Ac2-26-NP) reduced colitis activity postoperatively. Macroscopic wound closure improved, as evaluated by endoscopy and intraabdominal adhesion scoring. Microscopic analysis revealed an improved semiquantitative healing score in the treatment group. This proof-of-concept study demonstrates that novel P-C-Col IV-Ac2-26-NP could be a promising and clinically feasible perioperative treatment strategy for IBD patients undergoing intestinal surgery. The targeted delivery system shows potential for enhancing anastomotic healing and reducing postoperative complications in this IBD patient population.
- 25 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessOrally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery
Targeted perioperative therapeutics supporting anastomotic healing during colitis are an urgent medical need. This study aimed to develop and evaluate a novel nanoparticle (NP)-based drug delivery system for improving anastomotic healing in Inflammatory bowel disease (IBD) patients following surgery. We developed pectin-coated polymeric NPs encapsulating the inflammation-resolving peptide Ac2-26. These NPs are designed to survive gastric passage, facilitate localized release in the colon via microbial pectinase degradation, and bind to the intestinal wound through collagen IV targeting. We investigated these NPs in a murine surgical model combining intestinal anastomosis with preoperative colitis induction. Perioperative administration of pectin-chitosan coated NPs containing Ac2-26 (P-C-Col IV-Ac2-26-NP) reduced colitis activity postoperatively. Macroscopic wound closure improved, as evaluated by endoscopy and intraabdominal adhesion scoring. Microscopic analysis revealed an improved semiquantitative healing score in the treatment group. This proof-of-concept study demonstrates that novel P-C-Col IV-Ac2-26-NP could be a promising and clinically feasible perioperative treatment strategy for IBD patients undergoing intestinal surgery. The targeted delivery system shows potential for enhancing anastomotic healing and reducing postoperative complications in this IBD patient population.
- 28 September 2024
- Published by Springer Nature in Die Chirurgie
- Vol. 95 (11) , 895-900
Moderne Ansätze und Technologien zur Verhinderung der Anastomoseninsuffizienz am Gastrointestinaltrakt
Zusammenfassung Die Heilung gastrointestinaler Anastomosen ist ein komplexer biologischer Prozess, der von vielen Faktoren beeinflusst wird. Verschiedene Strategien zur Unterstützung der Heilung und Prävention von Anastomoseninsuffizienzen (AI) stehen zur Verfügung sowohl vor als auch während und nach der Operation. Präoperative Maßnahmen zielen darauf ab, den Patienten und das Milieu des Gewebes, insbesondere das Darmmikrobiom, in einen optimalen Zustand zu bringen. Intraoperative Maßnahmen sind technischer Natur und umfassen die Wahl des Operationszugangs, der Anastomosentechnik sowie der Anastomosenverstärkung. Verschiedene Verfahren der intraoperativen Diagnostik ermöglichen es, solche Anastomosen zu identifizieren, die weiteren protektiven Maßnahmen zugeführt werden müssen. In den letzten Jahren hat sich v. a. die Verwendung der Indocyaningrün(ICG)-Fluoroskopie etabliert, um die Perfusion des Gewebes zu evaluieren. Auch neuere Verfahren wie die Spektralmikroskopie bieten vielversprechende Möglichkeiten. Postoperativ sollen diagnostische Verfahren frühestmöglich eine AI identifizieren, um bereits vor dem Auftreten von Symptomen therapeutische Schritte einleiten zu können. Diese Verfahren reichen von verschiedenen Bildgebungsmethoden bis hin zu innovativen bioresorbierbaren, pH-sensiblen Implantaten zur AI-Früherkennung. Aufgrund der multifaktoriellen Genese der AI und der verschiedenen technischen Möglichkeiten wird sich nicht ein einzelnes Verfahren zur Prävention der AI etablieren, sondern eine Kombination von Maßnahmen, die schließlich zur optimalen Anastomosenheilung führen. Die Verwendung von künstlicher Intelligenz und darauf basierenden Analysen verspricht, die Fülle an Daten besser zu interpretieren und somit allgemeinere Empfehlungen geben zu können.
- 28 September 2024
- Published by Springer Nature in Die Chirurgie
- Vol. 95 (11) , 895-900
Moderne Ansätze und Technologien zur Verhinderung der Anastomoseninsuffizienz am Gastrointestinaltrakt
Zusammenfassung Die Heilung gastrointestinaler Anastomosen ist ein komplexer biologischer Prozess, der von vielen Faktoren beeinflusst wird. Verschiedene Strategien zur Unterstützung der Heilung und Prävention von Anastomoseninsuffizienzen (AI) stehen zur Verfügung sowohl vor als auch während und nach der Operation. Präoperative Maßnahmen zielen darauf ab, den Patienten und das Milieu des Gewebes, insbesondere das Darmmikrobiom, in einen optimalen Zustand zu bringen. Intraoperative Maßnahmen sind technischer Natur und umfassen die Wahl des Operationszugangs, der Anastomosentechnik sowie der Anastomosenverstärkung. Verschiedene Verfahren der intraoperativen Diagnostik ermöglichen es, solche Anastomosen zu identifizieren, die weiteren protektiven Maßnahmen zugeführt werden müssen. In den letzten Jahren hat sich v. a. die Verwendung der Indocyaningrün(ICG)-Fluoroskopie etabliert, um die Perfusion des Gewebes zu evaluieren. Auch neuere Verfahren wie die Spektralmikroskopie bieten vielversprechende Möglichkeiten. Postoperativ sollen diagnostische Verfahren frühestmöglich eine AI identifizieren, um bereits vor dem Auftreten von Symptomen therapeutische Schritte einleiten zu können. Diese Verfahren reichen von verschiedenen Bildgebungsmethoden bis hin zu innovativen bioresorbierbaren, pH-sensiblen Implantaten zur AI-Früherkennung. Aufgrund der multifaktoriellen Genese der AI und der verschiedenen technischen Möglichkeiten wird sich nicht ein einzelnes Verfahren zur Prävention der AI etablieren, sondern eine Kombination von Maßnahmen, die schließlich zur optimalen Anastomosenheilung führen. Die Verwendung von künstlicher Intelligenz und darauf basierenden Analysen verspricht, die Fülle an Daten besser zu interpretieren und somit allgemeinere Empfehlungen geben zu können.